Antiproliferative activity of taxol on human tumor and normal breast cells vs. effects on cardiac cells
Authors:
- 8 February 1995
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 60 (4) , 571-575
Abstract
The antiproliferative activity of the chemotherapeutic agent taxol was evaluated on 2 normal and 2 carcinoma human breast‐cell lines and compared with its effects on newborn rat cardiac cells growing in vitro. Relatively little difference in ID50 response (ranging from 0.6 to 2.0 ng/ml) to taxol was found between normal and tumorous breast epithelial cells. Arrhythmias and slowing of beat frequencies of cardiac cells were induced by taxol but at doses approximately 10 times higher than those necessary to inhibit proliferation in dividing cells. Microtubules assayed by immunostaining appeared to be similarly retracted around the nucleus in both breast and heart cells. Overall, our results suggest that taxol does not selectively inhibit the growth of tumor vs. normal human breast cells. They also support the hypothesis that effects on microtubule integrity are associated with effects on cardiac function and that the clinical cardiac activity of taxol already reported may be due, at least in part, to a direct effect of taxol on cardiac cells as demonstrated in these in vitro studies. Thus, caution is needed, in view of possible cardiac effects, when using taxol in future clinical protocols, especially when combined with other cardioactive agents such as Adriamycin.Keywords
This publication has 16 references indexed in Scilit:
- Cytoskeletal Role in the Contractile Dysfunction of Hypertrophied MyocardiumScience, 1993
- Characteristics of the combination paclitaxel plus doxorubicin in breast cancer cell lines analyzed with the ATP-Cell Viability AssayBreast Cancer Research and Treatment, 1993
- Immunophenotype of SV40-T gene transfected epithelial cell lines derived from human benign breast tumorsIn Vitro Cellular & Developmental Biology - Animal, 1992
- A nuclear protein essential for binding of rat 1,25-dihydroxyvitamin D3 receptor to its response elements.Proceedings of the National Academy of Sciences, 1992
- Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast CancerJNCI: Journal of the National Cancer Institute, 1991
- Taxol: A Novel Investigational Antimicrotubule AgentJNCI: Journal of the National Cancer Institute, 1990
- Effects of colchicine on cardiac cell function indicate possible role for membrane surface tubulinExperimental Cell Research, 1986
- Colchicine stimulates the rate of contraction of heart cells in cultureCardiovascular Research, 1983
- Promotion of microtubule assembly in vitro by taxolNature, 1979
- Cardiotoxicity of adriamycin and related anthracyclinesCancer Treatment Reviews, 1976